Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-105926
Filing Date
2023-10-02
Accepted
2023-10-02 16:40:17
Documents
6
Period of Report
2023-10-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2326633d2_def14a.htm DEF 14A 217645
2 GRAPHIC cellectar-pc_cs1.jpg GRAPHIC 382087
3 GRAPHIC cellectar-pc_cs2.jpg GRAPHIC 464011
4 GRAPHIC cellectar-pc_ps1.jpg GRAPHIC 406414
5 GRAPHIC cellectar-pc_ps2.jpg GRAPHIC 444090
6 GRAPHIC tm2326633d2_img1.jpg GRAPHIC 7377
  Complete submission text file 0001104659-23-105926.txt   2566129
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 231300259
SIC: 2834 Pharmaceutical Preparations